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Objective: To evaluate the effectiveness of a stroke-specific 
follow-up care model on quality of life for stroke patients, 
being discharged home, and their caregivers.
Design: A non-randomized, controlled trial, comparing an 
intervention group with a control group (usual care).
Subjects: Stroke patients and their caregivers.
Methods: Intervention involved 5 home visits by a stroke 
care coordinator over a period of 18 months, using a struc-
tured assessment tool. Outcome measures were conducted 
at baseline (T0) and every 6 months thereafter (T6, T12 and 
T18) in the domains of quality of life (primary), activities 
of daily living, social activities, depression, anxiety and car-
egiver strain.
Results: The intervention group (n = 62) had significantly 
increased its social activities after 18 months, whereas the 
control group (n = 55) showed significantly decreased levels 
of social activities. In the first 6 months, levels of depres-
sion decreased significantly in caregivers of the intervention 
group. No differences were found for quality of life and the 
other outcome measures. 
Conclusion: The intervention was not effective in improving 
quality of life, but was effective in improving levels of social 
activities. The intervention may have focussed too much on 
screening for stroke-related problems and not as much on 
adequate follow-up care and referral.
Key words: stroke; follow-up studies; long-term care; needs as-
sessment; quality of life.
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INtRoductIoN
Stroke survivors often experience problems in many different 
areas of functioning after being discharged home after hospi-
talization or inpatient rehabilitation. Stroke patients can have 
physical limitations (1), but cognitive and emotional problems 
can also occur (2, 3), which can lead to limitations in daily life 
and social activities (4). the lives of their caregivers can also 
be affected by the consequences of the stroke, as they often 
take partial or full responsibility for care provision, which can 
lead to caregiver burden or depression (5). these stroke-related 
problems are mostly long-lasting, requiring the provision of 
chronic care to patients and their caregivers (6). However, 
suitable long-term care is often lacking. New problems can 
emerge over time when patients no longer have contact with 
stroke care professionals. 
chronic care for stroke patients is complex because of the 
many domains of functioning affected, the occurrence of new 
problems over time, and the involvement of many different 
stroke care professionals. there does not currently seem to 
be consensus about the organization of chronic care services. 
In addition, patients are often unaware that certain problems 
may be stroke-related and therefore do not seek specific help 
(7). We believe that all stroke patients should be monitored 
regularly for more than 1 year after being discharged home and 
that those with needs should receive suitable follow-up care. 
With regard to type of care, several researchers have high-
lighted the importance of regularly monitoring stroke patients 
for issues other than somatic complaints, such as cognitive, psy-
chological and social functioning (6, 7). this may be achieved 
by using a comprehensive assessment tool covering all stroke-
related problems to detect the needs of stroke patients and their 
caregivers. Such an assessment was developed by Murray and 
colleagues (8), but this tool cannot yet be recommended for 
clinical use. the person carrying out the assessment, should 
preferably have sufficient knowledge of stroke, and the care 
professional should be able to provide multifaceted stroke care 
and be able to work with a multidisciplinary team. the preferred 
care professionals for this type of care might be general prac-
titioners (GPs), but stroke care coordinators (Scc) and social 
liaison workers can also provide equal or even better care than 
GPs on a wide range of chronic health problems (9). 
Provision of this multifaceted care, considering the many 
affected functions, should be organized in a multidisciplinary 
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system. this aspect has been studied more during the last 10 
years. there are many studies investigating the effectiveness 
of multidisciplinary care for stroke patients at home. only a 
few interventions however, were effective (10, 11), and these 
were very heterogeneous in terms of care provider, type of 
care provided and duration of care provision, and no specific 
factors can be identified that contributed to their effectiveness.
Aims and hypothesis
to our knowledge, there have been no studies evaluating a 
model of chronic care for stroke patients and their caregivers 
that included all the important long-term care aspects as de-
scribed above; regular monitoring, use of an assessment tool, 
coordinating follow-up care by a single healthcare professional, 
multidisciplinary care and follow-up care for more than 1 year. 
We therefore developed a new long-term care model for stroke 
patients and caregivers living at home after hospitalization or 
inpatient rehabilitation. this model involved the availability 
of long-term care for all stroke patients. A coordinating stroke 
care professional who collaborates with a multidisciplinary 
team, provided a structured assessment procedure by using 
an assessment tool, including 5 regular home visits over a 
period of 18 months leading to further follow-up care (such 
as advice, healthcare facilities and physical aids) or referral to 
other healthcare professionals (such as a physiotherapist or an 
occupational therapist). the present study evaluated the effec-
tiveness of this long-term care model in terms of the quality of 
life (qol) of stroke patients and their caregivers. We expected 
that the qol (primary outcome) would be higher and more 
improved in the group of patients and caregivers receiving the 
intervention (i.e. according to our chronic care model) than in 
the control group receiving care as usual. We also expected a 
difference in favour of the intervention group in terms of the 
secondary outcome domains of daily life functioning, social 
activities, emotional functioning and caregiver’s burden.
MEtHodS
Design
the study used a non-randomized, controlled trial design, comparing 
2 regional stroke services (intervention vs control) over a period of 
18 months. No changes to the methods were made after trial com-
mencement.
Study participants
consecutive stroke patients being discharged home from hospital or 
inpatient rehabilitation in the regions of Maastricht (intervention) and 
Eindhoven (control), both in the Netherlands, were eligible for partici-
pation in the study. Participants in the intervention group were included 
between 14 April 2008 and 31 december 2009, and participants in the 
control group were included between 1 September 2008 and 30 June 
2010. Inclusion criteria were: a diagnosis of stroke (confirmed by a 
neurologist); aged 50 years or older; living in the catchment area of 
the regional home care organization; and having sufficient command 
of dutch. Exclusion criteria for patients were: living in a nursing home 
before the stroke and a life expectancy of less than 3 months. the car-
egivers of the stroke patients were also asked to participate, based on 
the following criteria; being the primary caregiver of the stroke patient, 
being 18 years or older and having sufficient command of Dutch. The 
follow-up measurements were ended if the patient or caregiver refused 
to participate further, or if the patient moved to a nursing home or 
outside of the catchment area of the home care organization.
Intervention
the model for long-term care after stroke was developed for the 
Maastricht region, involving the following elements. All stroke patients 
were referred to a stroke care coordinator after being discharged home 
from hospital or inpatient rehabilitation. the Sccs were nurses from 
home care services specialized in stroke. the Scc visited the stroke 
patients at home 1–2 weeks and 3, 6, 12 and 18 months after discharge. 
More home visits were offered as needed. during each home visit the 
Scc administered a structured assessment tool (which we developed 
for the study) to assess a broad spectrum of stroke-related problems 
(activities of daily living, instrumental activities of daily living, social 
activity, cognition, communication, psycho-emotion, fatigue, second-
ary prevention, medical consumption, medical condition, caregivers’ 
strain and provision of information). Based on these assessments, the 
Scc provided suitable follow-up care during the home visits, such 
as giving information and advice or referred the patient to physi-
otherapists, occupational therapists and other healthcare professionals. 
After each home visit the Scc sent a written report to the patient’s 
general practitioner. the Scc could consult a multidisciplinary team 
of the nursing home (physician, physio therapist, occupational thera-
pist, speech therapist, social worker and psychologist) for advice as 
needed. the actual care for the included patients was recorded during 
the study period.
Control
the participants in the control group received the usual care provided 
in the Eindhoven region. Stroke patients with few or no residual effects 
were discharged home without follow-up care. Patients with more 
severe residual effects were discharged home and referred to a Scc 
of the home care service or of the stroke aftercare centre. Patients who 
were referred to the SCC of the home care service received their first 
home visit 6 weeks after being discharged home. Patients referred to the 
stroke aftercare centre had their first consult with a SCC at the centre 
after 3 months. Subsequently, one or more home visits or consultations 
could be provided as needed. No structured assessment procedure 
and pre-defined follow-up measurements were available. The actual 
care for the included patients was recorded during the study period.
Procedure
Shortly after being discharged home from hospitalization or inpatient 
rehabilitation, a Scc or nurse recruited the patient and their caregiver 
for the study. Patients and caregivers who agreed to participate were 
asked to give informed consent. After consent, patients and their 
caregivers were interviewed by the researcher to administer the 
outcome measures at baseline. The first interview with the researcher 
was arranged within 2–4 weeks at the patient’s home after being dis-
charged home (t0) and 6 (t6), 12 (t12) and 18 months (t18) later. 
the measurements of the study were performed independently and 
unrelated to the home visits of the care model, but they could affect 
each other, considering the time periods of the home visits and the 
study measurements. Medical records of the hospital were explored to 
gather information about the stroke and previous stroke history. this 
study was approved by the medical ethics committee of Maastricht 
university Medical centre. 
Outcome measures
the primary outcome measure for patients was the Stroke Adapted 
Sickness Impact Profile-30 (SASIP-30) as a measure of QoL (0–30; 
≥ 10 representing reduced QoL) (12). Secondary outcome measures 
were the Barthel Index (BI) to measure activities of daily living 
(Adl) (13) (0–20; < 10 representing Adl dependency), the frenchay 
Activities Index (fAI) to measure social activities (14) (0–45; 0–15 
representing inactivity), and the Hospital Anxiety depression Scale 
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(HADS) to measure depression and anxiety (15) (0–21; ≥ 11 represent-
ing depression or anxiety disorder). the primary outcome measure 
for caregivers was the life Satisfaction questionnaire-9 (liSAt-9) as 
a measure of the qol (1–9; no norms were available, therefore we 
used the reference values of stroke patients in a study with a mean of 
4.5 and standard deviation of 0.8; a higher score representing greater 
satisfaction) (16). the secondary outcome measures were the HAdS 
and the caregivers Strain Index (cSI) to measure caregiver’s burden 
(17) (0–13; > 7 representing caregiver’s strain). All measures have 
good reliability and validity. No outcome measures were changed 
after trial commencement.
Statistical analysis
Means, standard deviations or percentages were used to describe 
participants’ and disease characteristics. differences in these char-
acteristics between the intervention and control group were analysed 
by independent samples t-tests and χ2 tests, where appropriate. Non-
parametric tests were used, in case normality assumptions were vio-
lated, by which medians and percentiles were presented. to determine 
the effects of the intervention, mean change scores were calculated 
using baseline measures as a reference. due to skewed distributions 
and a small number of participants, the median change scores were 
presented. differences in median change scores were tested using 
Mann-Whitney U tests. In addition, within group differences were 
analysed using Wilcoxon signed-rank tests. Patients and caregivers 
were included in the analyses when they had taken part in one or more 
follow-up measurements. 
to check for possible confounding, participant characteristics 
were entered as covariates in linear regression analyses where the 
mean change score was the dependent variable and the group was 
the primary independent variable, for each follow-up measurement. 
The influences of the following patient characteristics were checked 
stepwise for confounding: sex, age, comorbidity, marital status, educa-
tion, type of stroke, institution of discharge, and time between stroke 
and discharge. the following caregiver characteristics were checked 
stepwise for confounding: sex, age, number of hours of caregivers’ 
activities, relationship, and education. A variable was considered a 
strong confounder when inclusion of the variable in the linear regres-
sion model changed the coefficient of the independent variable group 
by more than half of its standard error. When the covariate was not 
a strong confounder, the covariate was removed and other covariates 
were entered in the model. When a confounder was identified at one of 
the 3 mean change scores (t6–t0, t12–t0 or t18–t0) of a dependent 
variable, a correction was applied to all 3 mean change scores of this 
dependent variable.
A power calculation, assuming an independent samples t-test, 
indicated a minimal sample size of 76 patients per group to obtain a 
power of 80% for an effect size of 0.5 on the scores of the SASIP-30 
(medium effect) (18), with 2-sided alpha of 0.05. this calculation ac-
counts for an expected drop-out rate of 15%. SPSS (version 18) was 
Fig. 1. Inclusion of stroke patients and follow-up measurements.
Patients receiving baseline measure (n=55) 
 
!
Patients receiving measure (n=51) 
Missing: no contact (n=3) / refused (n=1) 
 
Patients receiving measure (n=45) 
Missing: no contact (n=4) / refused (n=2) 
 
Patients receiving measure (n=43) 
Maastricht 
 
Assessed for eligibility (n=171)  
(14th April 2008 to 31th Dec. 2009) 
Excluded 
 Not meeting inclusion criteria 
 Refused to participate 
 Other reasons 
Patients receiving baseline measure (n =62) 
Allocated to intervention (n=77)  
Missing at T0: no contact (n=2) / refused (n=5) 
Deceased at T0/Drop-out after T0 (n=4/ n=4)
 
 
Allocated to control (n=67)  
Missing at T0: no contact (n=9) / refused (n 1) 







Assessed for eligibility (n=125)  









Patients receiving measure (n =52) 
Missing: no contact (n =7) / refused (n =3)  
Patients receiving measure (n=56) 
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used for all statistical analyses. two sided p-values smaller than 0.05 
were considered significant. 
RESultS
Participant’s characteristics
In the Maastricht region, the results of 62 patients and 41 care-
givers were included in the analyses. In the Eindhoven region, 
the results of 55 patients and 33 caregivers were included in 
the analyses. fig. 1 shows the inclusion process of the patients 
and their follow-up measurements and fig. 2 presents the inclu-
sion process and follow-up measurements of the caregivers. 
Patient characteristics are given in table I. the patients in 
the intervention group had more comorbidity than the control 
group, particularly with regard to locomotor apparatus. table 
II summarizes the caregiver characteristics and showed that 
caregivers in the control region provided more care regarding 
transfer and mobility to stroke patients than caregivers in the 
intervention region. there were no differences found in the 
baseline characteristics and scores of the dropped-out patients.
Table III shows the 6 major problems that were identified using 
the structured assessment tool by the Scc during the follow-up 
visits in the intervention group. fatigue, cognitive complaints and 
instrumental activities of daily living problems were mentioned by 
more than half of the patients during the first 2 visits in the first 6 
months and by more than one-third of the patients at later visits.
Received care
Patients in the intervention group received a mean of 3.9 
home visits and 11% received care longer than 18 months. In 
the control group, 30 patients received no follow-up care, 15 
patients received care from the Sccs (mean 2.4 home visits 
over a mean period of 5.5 months) and 10 patients received 
care from the stroke care centre (mean 1.1 consults over a 
mean period of 3.5 months).
Primary outcome
Patients. table Iv lists the median scores of the patients in 
both groups, for each follow-up measurement. the interven-
tion group had a higher score on the SASIP than the control 
group at 18 months follow-up, although the difference was not 
significant. Median change scores showed a decline over time 
in both groups on the SASIP, but the difference between the 
Fig. 2. Inclusion of caregivers and follow-up measurements
Caregivers receiving baseline measure (n=33) 
 
!
Caregivers receiving measure (n=27) 
Missing: no contact (n=5) / refused (n=1) 
 
Caregivers receiving measure (n=26) 
Missing: no contact (n=5) / refused (n=0) 
 
Caregivers receiving measure (n=26) 
Maastricht 
 
Assessed for eligibility (n=72)  
(14th April 2008 to 31th Dec. 2009) 
Excluded 
 Not meeting inclusion criteria 
 Refused to participate 
 Other reasons 
Caregivers receiving baseline measure (n=41) 
Allocated to intervention (n=60)  
Missing at T0: no contact (n=5) / refused (n=1) 
Deceased/Drop-out after T0 (n=1/n=12)
 
 
Allocated to control (n=40)  
Missing at T0: no contact (n=4) / refused (n=1) 







Assessed for eligibility (n=40)  









Caregivers receiving measure (n=33) 
Missing: no contact (n=6) / refused (n=2) 
Caregivers receiving measure (n=32) 
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table I. Patient characteristics
Intervention
(n = 62) 
control
(n = 55) p-value
Age, years, mean (Sd) 72.7 (10.0) 71.1 (8.4) 0.364 (t)
Gender, male, n (%) 32 (51.6) 31 (56.4) 0.607 (χ2)
time since stroke, months, median [IqR] 2.0 [1–3] 1.0 [1–3] 0.955 (U)
Marital status, n (%)
couple 32 (51.6) 32 (58.2) 0.476 (χ2)
Single 30 (48.4) 23 (41.8)
Education, n (%)
low 29 (47.5) 23 (41.8)
0.722 (χ2)Middle 21 (34.4) 19 (34.5)
High 11 (18.1) 13 (23.6)
Missing 1 –
Stroke type, n (%)
Infarction 51 (82.3) 48 (90.6)
0.199 (χ2)Bleeding 11 (17.7) 5 (9.4)
Missing – 2
thrombolyses 9 (14.8) 8 (14.5) 0.993 (χ2)
Stroke location, n (%)
left hemisphere 26 (41.9) 27 (50.0)
0.294 (χ2)Right hemisphere 24 (38.7) 22 (40.7)
others 12 (19.4) 5 (9.3)
Missing – 1
Previous history, n (%)
Patients with other diseases 51 (83.6) 37 (67.3) 0.040 (χ2)
cardiovascular diseases 24 (38.7) 18 (32.7) 0.233 (χ2)
locomotor apparatus 16 (25.8) 3 (5.5) 0.001 (χ2)
Previous cerebrovascular event 8 (12.9) 8 (14.5) 0.823 (χ2)
Pulmonary diseases 5 (8.1) 7 (12.7) 0.540 (χ2)
diabetes 5 (8.1) 7 (12.7) 0.479 (χ2)
Patient > 1 other diseases 25 (40.3) 16 (29.6) 0.006 (U) 
discharged from, n (%)
Hospital 44 (71.0) 47 (85.5)





Median 8.0 6.0 0.135 (U)
IqR 5–13 3–6




Median 20.0 20.0 (5–20) 0.267 (U)
IqR 18.5–20 19–20
n (% below cut-off score (< 10)) 4 (6.5) 1 (1.8)
fAI
n 62 55
Median 17.5 27.0 < 0.001 (u)
IqR 9–25 20–32
n (% below cut-off score (< 15)) 25 (40.3%) 6 (10.9)
HAdS anxiety
n 61 55
Median 4.0 4.0 0.643 (U)
IqR 1–8 2–7
n (% above cut-off score (≥ 11)) 4.0 (6.5) 5 (9.1)
HAdS depression
n 61 55
Median 4.0 3.0 0.376 (U)
IqR 2–7.5 2–7
n (% above cut-off score (≥ 11)) 5.0 (8.1) 3 (5.5)
Sd: standard deviation; t: t-test; χ2: chi-square test; U: Mann-Whitney U test; SASIP-30: Stroke Adapted Sickness Impact Profile-30; BI: Barthel 
Index; fAI: frenchay Activities Index; HAdS: Hospital Anxiety depression Scale; IqR: interquartile range.
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2 groups regarding these changes was not significant (T6–T0, 
p = 0.055; t12–t0, p = 0.354; t18–t0, p = 0.416) (table v). 
Caregivers. Table VI shows that there was a significant dif-
ference in caregiver’s median scores on the liSAt-9 at the 18 
months follow-up, in favour of the control group (p = 0.005). 
Median change scores for the liSAt-9 showed no change from 
baseline over time in either of the groups (table vII).
Secondary outcomes
Patients. Median changes in the outcomes of the fAI scores 
indicated significant changes from baseline at 6 (p < 0.001), 12 
(p = 0.006) and 18 months (p < 0.001). Patients in the interven-
tion group showed a positive change, whereas the control group 
showed a negative change. Sub-analyses of the median scores 
at baseline and t6 within the 2 groups showed that the levels 
of social activities improved significantly within the first 6 
months in the region of Maastricht (p < 0.001), but a significant 
decrease was found in the region of Eindhoven (p = 0.033). 
After 6 months, the median fAI scores of both group were 
stable (i.e. no significant changes) and comparable. The median 
BI scores were high at each follow-up measure in both groups 
(60–85% having the maximum score), which shows that the 
majority of patients were (almost) fully independent in terms 
of Adl. With regard to median changes over time, there were 
no significant differences between the groups as regards the 
BI outcome. there were no differences between the 2 groups 
in terms of the HADS anxiety scale. There was a significant 
change in the HAdS depression scale scores between t12 and 
t0 (p = 0.048) in favour of the intervention group. 
Caregivers. table vI shows the median scores for the second-
ary outcome measures for caregivers, and table vII shows the 
median change scores. caregivers in the intervention group 
had higher median scores on the HAdS anxiety and depres-
sion scale at most of the follow-up measures compared with 
the control group, but the differences were not significant. 
the cSI scores remained low at each follow-up measurement 
and there were no significant differences between the groups. 
the changes in the caregiver’s scores on the HAdS depres-
sion scale between baseline and 6 months follow-up differed 
significantly between the groups in favour of the intervention 
group (p = 0.028). There were no other significant differences 
between the 2 groups as regards the changes over time.




(n = 33) p-value
Age, years, mean (Sd) 63.7 (14.5) 64.9 (11.1) 0.638 (t)
Gender, male, n (%) 10 (24.4) 9 (27.3) 0.097 (χ2)
Relationship, n (%)
Spouse 29 (70.7) 27 (81.8) –
child 9 (22) 5 (15.2)
other 3 (7.3) 1 (3)
Marital status, n (%)
couple 35 (85.4) 29 (87.9) –
Single 6 (14.6) 4 (12.1)
Education, n (%)
low 17 (41.5) 10 (30.3)
0.471 (χ2)Middle 17 (41.5) 14 (42.4)
High 7 (17.1) 9 (27.3)
caregivers’ activities
Hours a week, median 10 8.5 0.677 (U)
IqR 4.8–17.5 1–18.8
type of activity performed, n (%)
Personal care 10 (24.4) 5 (15.2) 0.359 (χ2)
Mobility and transport 20 (48.8) 24 (72.7) 0.006 (χ2)
House holding activities 26 (63.4) 22 (66.7) 0.502 (χ2)
finances and mail 14 (34.1) 16 (48.5) 0.132 (χ2)





Median 4.9 5.1 0.036 (U)
IqR 4–5.2 4.8–5.4




Median 5.0 3.0 0.003 (U)
IqR 3–9 1–6
n (% above cut-off score (≥ 11)) 5 (12.2) 4 (12.1)
HAdS depression
n 41 33
Median 4.0 2.0 0.035 (U)
IqR 2–7 0.5–5




IqR 1–6 1–6.5 0.781 (U)
n (% above cut-off score (> 7)) 7 (18.9) 8 (24.2)
Sd: standard deviation; t: t-test; χ2: chi-square test; U: Mann-Whitney U 
test; liSAt-9: life Satisfaction questionnaire-9; HAdS: Hospital Anxiety 
depression Scale; cSI: caregivers Strain Index; IqR: interquartile range.












fatigue 78 64 44 48 39
Instrumental Adl 61 61 41 41 28
Medical status 50 43 32 – 28
cognition 46 50 29 38 33
Social activity 46 50 – 41 –
lack of information 41 – – – –
communication – 43 24 38 33
Adl – – 29 – –
Psycho-emotional – – – 34 17
Adl: activities of daily living.
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table Iv. Median scores of the outcomes of patients at baseline and the follow-up measures


















SASIP-30 61 (8.0) [5 to 13] 55 (6.0) [3–6] 52 (5.0) [2–13] 51 (5.0) [2–11] 56 (6.5) [3–12] 45 (5.0) [2.5–129] 58 (6.0) [3–10] 43 (4.0) [1–9]
Secondary outcomes
BI 62 (20.0) [18.5–20] 55 (20.0) [19–20] 52 (20.0) [19–20] 51 (20.0) [19–20] 56 (20.0) [18–20] 45 (20.0) [19.5–20] 58 (20.0) [19–20] 43 (20.0) [20–20]
fAI 62 (17.5) [9–25]* 55 (27.0) [20–32]* 51 (24.0) [20–31] 51 (24.0) [16–31] 55 (22.0) [16–30] 45 (25.0) [19–31] 58 (24.0) [14–28] 43 (23.0) [17–30]
HAdS A 61 (4.0) [1–8] 55 (4.0) [2–7] 52 (3.0) [1–7] 51 (2.0) [1–6] 55 (2.0) [0–6] 45 (3.0) [1–6.5] 58 (2.0) [1–5] 43 (2.0) [1–5]
HAdS d 61 (4.0) [2–7.5] 55 (3.0) [2–7] 52 (3.5) [1–8] 51 (3.0) [1–7] 55 (3.0) [1–7] 45 (4.0) [1–8] 58 (3.0) [1–7] 43 (2.0) [0–6]
*Significant differences between groups.
SASIP-30: Stroke Adapted Sickness Impact Profile-30; BI: Barthel Index; FAI: Frenchay Activities Index; HADS A: Hospital Anxiety Depression Scale – Anxiety subscale; 
HAdS d: Hospital Anxiety depression Scale – depression subscale; IqR: interquartile range.















SASIP-30 51 (–2.0) [–5 to 0] 51 (0.0) [–3 to 2] 55 (–2.0) [–4 to 1] 45 (0.0) [–3.5 to 2] 57 (–2.0) [–4 to 1] 43 (–1.0) [–5–2]
Secondary outcomes
BI 52 (0.0) [0 to 0.8] 51 (0.0) [0 to 0] 56 (0.0) [–1 to 0] 45 (0.0) [0 to 0] 58 (0.0) [0 to 0] 43 (0.0) [0 to 0]
fAI 51 (6.0) [0 to 13]* 51 (–3.0) [–8 to 4]* 55 (3.0) [–4 to 10]* 45 (–1.0) [–5.5 to 2]* 58 (3.5) [–3.3 to 9.3]* 43 (–4.0) [–9 to 0]*
HAdS A 51 (0.0) [–3 to 2] 51 (–1.0) [–3 to 1] 54 (–1.0) [–3 to 1] 45 (–1.0) [–3 to 1] 57 (–1.0) [–3.5 to 1] 43 (–1.0) [–3 to 1]
HAdS d 51 (–1.0) [–3 to 1] 51 (0.00) [–2 to 2] 54 (0.0) [–2.3 to 1]* 45 (0.0) [–1 to 3]* 57 (–1.0) [–2.5 to 1] 43 (0.0) [–2 to 1]
*Significant differences between groups.
SASIP-30: Stroke Adapted Sickness Impact Profile-30; BI: Barthel Index; FAI: Frenchay Activities Index; HADS A: Hospital Anxiety Depression Scale – Anxiety subscale; 
HAdS d: Hospital Anxiety depression Scale – depression subscale; IqR: interquartile range. 
table vI. Median scores of the outcomes of caregivers at baseline and the follow-up measures


















liSAt-9 41 (4.9) [4–5.2]* 33 (5.1) [4.8–5.4]* 33 (4.9) [4.5–5] 27 (5.0) [4.8–5.2] 32 (5.0) [4.6–5.2] 26 (5.0) [4.4–5.4] 34 (4.7) [4.4–5]* 26 (5.0) [4.9–5.3]*
Secondary outcomes
HAdS A 41 (5.0) [3–9]* 33 (3.0) [1–6]* 30 (5.0) [3–11] 27 (4.0) [1–8] 31 (4.0) [1–6] 26 (3.0) [1.8–6] 34 (4.0) [1–9.3] 26 (2.0) [1–5]
HAdS d 41 (4.0) [2–7]* 33 (2.0) [0.5–5]* 30 (2.5) [1–8] 27 (3.0) [1–5] 31 (2.0) [0–5] 26 (2.0) [1–4.3] 34 (2.0) [1–7] 26 (2.0) [0.8–3.3]
cSI 37 (4.0) [1–6] 33 (4.0) [1–6.5] 32 (2.0) [1–4] 27 (3.0) [1–5] 31 (3.0) [1–5] 26 (3.5) [0.8–7.3] 34 (2.0) [0.8–5] 26 (2.0) [0–6]
*Significant differences between groups.
liSAt-9: life Satisfaction questionnaire-9;  HAdS: Hospital Anxiety depression Scale; HAdS A: Hospital Anxiety depression Scale – Anxiety subscale; HAdS d: 
Hospital Anxiety depression Scale – depression subscale; cSI: caregivers Strain Index; IqR: interquartile range.















liSAt-9 33 (0.0) [–0.2 to 0.4] 27 (–0.1) [–0.3 to 0.2] 32 (0.0) [–0.2 to 0.6] 26 (–0.1) [–0.7 to 0.2] 34 (0.0) [–0.5 to 0.6] 26 (–0.1) [–0.2 to 0.1]
Secondary outcomes
HAdS A 30 (0.0) [–2.3 to 3] 27 (1.0) [–1 to 2] 31 (–2.0) [–5 to 1] 26 (0.0) [–1.3 to 2.3] 34 (–2.5) [–4.3 to 1] 26 (0.0) [–2.3 to 2.3]
HAdS d 30 (–1.0) [–2.3 to 0]* 27 (0.0) [0 to 1]* 31 (–1.0) [–2 to 1] 26 (0.0) [–1 to 1] 34 (–1.0) [–4 to 0] 26 (0.0) [–2.3 to 1]
cSI 30 (–1.0) [–3.3 to 1] 27 (–1.0) [–4 to 0] 28 (–1.0) [–2 to 1] 26 (0.0) [–3 to 1] 31 (–1.0) [–4 to 1] 26 (–0.5) [–3.3 to 1]
*Significant differences between groups.
liSAt-9: life Satisfaction questionnaire-9; HAdS A: Hospital Anxiety depression Scale – Anxiety subscale; HAdS d: Hospital Anxiety depression Scale – depression 
subscale; cSI: caregivers Strain Index; IqR: interquartile range.
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Confounding factors
Patients. the analyses to identify confounding factors indi-
cated that comorbidity and the institution of discharge had a 
strong influence on the outcome in terms of SASIP scores. 
the effect of the intervention on the BI outcome was changed 
when the institution of discharge was included in the analysis. 
The HADS anxiety scale score was influenced by comorbidity 
and type of stroke. there were no patient characteristics that 
influenced the effect of group on the FAI score or the HADS 
depression scale score. the correction for confounding patient 
characteristics did not change the differences in outcomes 
between the 2 groups.
Caregivers. the effect of the intervention on the liSAt-9 
scores was not influenced by any of the caregiver character-
istics. the effect of the intervention on the outcome in terms 
of the HAdS anxiety and depression scale and the cSI were 
all influenced by the number of hours of caregivers’ activities. 
the difference in outcome between the groups did not change 
after correction for the confounding variable. 
dIScuSSIoN
the results of our study showed that the qol of the patients 
has improved over time in both groups. However, there were 
no significant differences in the change over time between the 
2 groups. the qol of the caregivers in the control group was 
higher than in the intervention group after 18 months, but there 
was no significant difference in the changes since baseline 
between the groups. Patients in the intervention group showed 
a significant increase in social activities after 18 months com-
pared with baseline, whereas the social activities of the patients 
in the control group decreased. the levels of depression of the 
caregivers in the intervention group changed positively and 
differently from the levels of depression of the caregivers in 
the control group within the first 6 months after baseline. 
the positive effects on the levels of social activities in the 
intervention group, of which most effects were shown in the first 
6 months, are consistent with earlier studies that showed an im-
provement in social activities within the first year after a stroke 
(19, 20). this increased level of social activities is an important 
gain, because it remains stable over time: approximately 76% 
of the stroke patients maintained their level of social activities 
3 years post-stroke (21). Moreover, other studies have indicated 
that social inactivity is positively associated with depression 
and lower levels of qol (22). the differences in changes in the 
level of social activities between the intervention and control 
group within the first 6 months could also be explained by dif-
ference in comorbidity. Patients in the intervention group had 
more locomotor problems and could therefore be more inactive 
at baseline than patients in the control group. follow-up care in 
the intervention could have been more focused on improving the 
physical condition of patients, which might have led to being 
more socially active. Jansen and colleagues (21) have recom-
mended that stroke care professionals should direct special at-
tention to patients who are inactive at an early stage after stroke 
(21). the level of social activities of both groups after 6 months 
seems to be in line with other studies that have measured social 
activity in stroke patients at home (1, 21).
the lack of effect could also have a methodological ex-
planation, because the total number of participating patients 
was lower that the calculated sample size. lack of effect on 
the qol of stroke patients was also found by Boter and col-
leagues (22) studying the effect of follow-up care by means of 
telephone follow-up consultations performed by specialized 
stroke nurses (23). they concluded that follow-up consulta-
tions and giving attention and advice alone may not have 
been enough, and adequate follow-up care should be offered 
in addition to assessing problems in daily functioning. In the 
present study, follow-up care was offered to the patients and 
their caregivers, but the patients received a mean of 3.9 visits 
instead of the intended 5, 23% received care for 18 months 
and the follow-up initiated by the Scc after assessment was 
not as good as intended. this could have reduced the effect of 
the intervention on the qol. Perhaps, more attention should 
have been paid to the follow-up care in addition to assess-
ment. More details about organizational limitations will be 
discussed in the process evaluation, which was performed in 
parallel with this study. In addition, part of our control group 
also received intensive follow-up care, which was developed 
during the study period, because of the increasing emphasis 
on more follow-up care for stroke patients in the Netherlands. 
Interestingly, many patients with relatively good functional 
outcomes participated in our study. 
this study has several strengths and limitations, which 
should be considered when interpreting the results. A strength 
is that this study is one of the first controlled studies on long-
term care for stroke patients. furthermore, this study addresses 
a broad spectrum of stroke-related problems, which were not 
measured previously in other intervention studies. thirdly, 
stroke patients in the primary care setting participated in the 
study and the study had a reasonable sample size. there are also 
several limitations. first, the study did not have a randomized 
design and the results of 2 groups from 2 different regions 
could be affected by regional differences, which could explain 
the baseline differences between groups. Next, there may be a 
population bias because patients with good functional recovery 
consented to participate. furthermore, we lost several data due 
to drop-out of patients and caregivers during the study period. 
Most patients dropped-out at the beginning of the study because 
the study put too much burden on the patients early after stroke. 
this drop-out could have caused a selection bias. In the control 
region, there was also drop-out due to difficulties during the 
inclusion period and 8 patients were not interviewed, due to 
organizational problems. In addition, the follow-up care was 
developed in the control region during the study period, and this 
might have decreased the contrast between the 2 groups in our 
study. Such changes over time cannot be prevented in studies 
with a longitudinal design, but researchers should be aware of 
this. Based on our study, we would suggest tight organization 
in the control region, with rapid inclusion, consistent contact 
persons and intensive monitoring during the inclusion period. 
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our study shows that the long-term care model is effective 
in terms of social activities but not qol of stroke patients. 
We would like to highlight that screening of stroke-related 
problems could be the first step in providing adequate care. A 
more structured guideline for referral to stroke care profession-
als could be necessary in order to gain a substantial additional 
improvement in the qol of patients and caregivers. future 
research should therefore investigate adequate follow-up care 
in addition to problem assessment as part of the integrated care 
pathway. Specific programmes have already been evaluated and 
showed positive results, such as cognitive rehabilitation (24) 
for cognitive problems and cognitive behavioural therapy for 
the treatment of fatigue (25), which are 2 of the main long-
term problems.
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